Predictors of in-hospital mortality AND death RISK STRATIFICATION among COVID-19 PATIENTS aged ≥ 80 YEARs OLD.


Journal

Archives of gerontology and geriatrics
ISSN: 1872-6976
Titre abrégé: Arch Gerontol Geriatr
Pays: Netherlands
ID NLM: 8214379

Informations de publication

Date de publication:
Historique:
received: 24 01 2021
revised: 15 02 2021
accepted: 18 02 2021
pubmed: 7 3 2021
medline: 5 6 2021
entrez: 6 3 2021
Statut: ppublish

Résumé

To date, mainly due to age-related vulnerability and to coexisting comorbidities, older patients often face a more severe COVID-19. This study aimed to identify at Emergency Department (ED) admission the predictors of in-hospital mortality and suitable scores for death risk stratification among COVID-19 patients ≥ 80 years old. Single-centre prospective study conducted in the ED of an university hospital, referral center for COVID-19 in central Italy. We included 239 consecutive patients ≥ 80 years old with laboratory-confirmed COVID-19. The primary study endpoint was all-cause in-hospital mortality. Multivariable Cox regression analysis was performed on significant variables at univariate analysis to identify independent risk factor for death. Overall performance in predicting mortality of WHO severity scale, APACHE II score, NEWS score, and CURB-65 was calculated. Median age was 85 [82-89] and 112 were males (46.9%). Globally, 77 patients (32.2%) deceased. The presence of consolidations at chest x-ray and the hypoxemic respiratory failure were significant predictors of poor prognosis. Moreover, age ≥ 85 years, dependency in activities of daily living (ADL), and dementia were risk factors for death, even after adjusting for clinical covariates and disease severity. All the evaluated scores showed a fairly good predictive value in identifying patients who could experience a worse outcome. Among patients ≥ 80 years old hospitalized with COVID-19, not only a worse clinical and radiological presentation of the disease, but also the increasing age, dementia, and impairment in ADL were strong risk factors for in-hospital death, regardless of disease severity.

Identifiants

pubmed: 33676091
pii: S0167-4943(21)00046-7
doi: 10.1016/j.archger.2021.104383
pmc: PMC7904458
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104383

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Marcello Covino (M)

Emergency Department - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy.

Giuseppe De Matteis (G)

Department of Internal Medicine - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. Electronic address: giuseppe.dematteis@policlinicogemelli.it.

Davide Antonio Della Polla (DAD)

Emergency Department - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Michele Santoro (M)

Emergency Department - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Maria Livia Burzo (ML)

Emergency Department - Ospedale Generale M.G. Vannini, Istituto Figlie di San Camillo, Rome, Italy.

Enrico Torelli (E)

Emergency Department - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Benedetta Simeoni (B)

Emergency Department - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Andrea Russo (A)

Geriatrics Department - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Claudio Sandroni (C)

Department of Anesthesiology and Intensive Care Medicine - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy.

Antonio Gasbarrini (A)

Department of Internal Medicine and Gastroenterology - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy.

Francesco Franceschi (F)

Emergency Department - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH